Home | Back to newsletter main page
| |
 |
|
March 28, 2011 |
|
MESSAGE FROM THE DIRECTORRuth Keri PhD, Appointed Associate Director for Basic Research, Case Comprehensive Cancer Center
After a national search, I am delighted to announce the appointment of Ruth Keri, PhD, to the position of Associate Director for Basic Research, Case Comprehensive Cancer Center. Dr. Keri is an associate professor in the departments of pharmacology, genetics and oncology at CWRU. She received her PhD in the department of pharmacology here in 1992, working at the time on identifying the regulatory mechanisms underlying pituitary gonadotropin hormone gene expression using novel transgenic mouse models. Her interest in the effects of reproductive hormones led to her long-standing interest in breast cancer, and a more recent interest in human breast cancer. She has done a remarkable job linking basic and animal model research to human disease, and in developing the key translational teams that are required for such complex research activities. She serves on a number of NIH and DOD scientific review panels, has been identified as a key investigator in breast cancer, and is recognized as a top educator in the department of pharmacology. Recently, Dr. Keri's research activities have been to interrogate the role of HER2/c-neu/erbB2 in tumor progression and the impact of a variety of inhibitors on the signaling pathways activated by this receptor, to understand the role of FOXA1 in normal mammary ductal morphogenesis and breast tumor phenotypes, to understand the function of a Kruppel-like factor in epithelial to mesenchymal transition and metastasis, and to evaluate the role of LMO4 in breast-cancer proliferation. In her position as associate director, Ruth will work with the Cancer Center leadership to develop the priorities and scientific direction of the Center, and will work with the leaders of all programs involved in basic laboratory investigation with an orientation towards promoting translational and disease-based research amongst investigator teams. Dr. Keri will be central to the development of a strategic plan for the Cancer Center, moving us into current preparations for our renewal application due in May of 2012. Please feel free to contact Dr. Keri regarding any of these initiatives or about her own research. I am sure you will hear more from her soon as she begins to participate in program and scientific focus area meetings. Stan Gerson, MD CASE CCC IN THE NEWSStudies Link Missing Gene to Drug-Resistant Cancers ANNOUNCEMENTSNew MembersPlease join us in welcoming the newest members of the Case CCC: Stanley Hazen, PhD Steve Huang, MD, PhD Gary Landreth, PhD Gordon McLennan, MD Vincent Tuohy, PhD MARK YOUR CALENDARSCase CCC Scientific SeriesThe next installment of the Case CCC Scientific Series is scheduled for Thursday, April 21 from 4-6:30 pm in Wolstein Auditorium (WRB 1-413). Drs. Anton Gorbachev, Neetu Gupta and Alex Huang will discuss the topic of Immunology. Presentations will be followed by a short receptions. All are encouraged to attend. 2nd Annual Department of Medicine Research DayDepartment of Medicine faculty and trainees are invited to participate in the 2nd Annual Department of Medicine Research Day, Monday, May 16 from 12-5 pm in the Wolstein Research Building auditorium and lobby. The mission of Research Day is twofold. First is to recognize and showcase the wide range of research in the Department by our young investigators at all levels of training. Second, is to provide an opportunity for departmental faculty to share ideas and knowledge and to stimulate discussion about opportunities for collaboration. All Department of Medicine faculty and trainees are encouraged to attend this important event. In addition, young researchers (faculty within 5 years of appointment, fellows, residents and post-doctoral and graduate students) are invited to submit abstracts for poster presentation. Visit the event webpage for details. Case CCC Annual Scientific RetreatThe Case CCC Annual Scientific Retreat will be July 8-9 at Corporate College East. Details will be posted soon. FUNDING OPPORTUNITIESUniting Against Lung CancerUniting Against Lung Cancer is accepting applications for the 2011 Legacy Program for Advances in Lung Cancer Research. In 2011, the program is prioritizing innovative, high risk/high reward research, with an aim towards jumpstarting new projects leading to improved treatments and a cure for lung cancer, including non-small cell and small cell lung cancer. Proposals do not require large amounts of preliminary data, but must have a clear hypothesis and research plan to be completed within the two year grant term. This funding is intended primarily as seed money for promising and potentially transformative new projects, rather than funding well-developed clinical projects that already receive considerable support. However, high risk/high reward add-on studies leveraging larger ongoing projects, or pre-existing data-sets, clinical samples, etc. are of interest. Investigators at all levels will be funded through the Legacy Program and are encouraged to apply. Deadline: August 17 NCI CANCER BULLETINMarch 22News Commentary In Depth Updates |
EVENTS
**All events are open to anyone interested in attending March 28Pathology Research Seminar Cancer Imaging Program (CIP) Microenvironment Focus Group "Mini Talk" SDIG Meeting Physiology and Biophysics Seminar March 29Cellular and Molecular Biology of Disease: A Symposium Series Cancer Biology Invited Speaker Seminar Immunology Seminar Special Seminar Cellular and Molecular Biology of Disease: A Symposium Series March 30Hematology and Oncology Division Research Conference March 3113th Lerner Lecture April 1Cancer Center Research in Progress Seminar canceled- AACR Cancer Center Seminar Series canceled-AACR Hematology/Oncology Fellows Taussig Cancer Institute Grand Rounds
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSBreast Cancer Detection and Management: Issues for 2011 Case CCC Annual Scientific Retreat ADDITIONAL UPCOMING SEMINARS & EVENTS4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science Fourth Annual Translational to Clinical (T2C) Wound Care Conference Midwest Blood Club 9th Annual Symposium 2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting Cincinnati Cancer Symposium Series: 2011 Symposium on NF-κB, Cancer, Obesity, and Inflammation 4th International Symposium on Cancer Metastasis and the Lymphovascular System Race for the Place International Society for Stem Cell Research (ISSCR) Annual Meeting Cancer Health Disparities Summit 2011 8th International Conference of the Society for Integrative Oncology |
|
|
|
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
|
|
Multiple Myeloma Research Foundation 2011 Research Fellow Award Program |
Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC) |
NIH BULLETIN – Notices and Funding OpportunitiesResearch on Ethical Issues in Biomedical, Social and Behavioral Research (R01) (PA-11-180) Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R21) (PA-11-182) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|